SMTL ID : 5k7k.1

Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7: Discovery of Clinical Candidate PF-05089771

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.30 Å
Oligo State
monomer
Ligands
1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
1 x 6RJ: 4-[4-chloranyl-2-(1~{H}-pyrazol-4-yl)phenoxy]-3-cyano-~{N}-(1,3-thiazol-2-yl)benzenesulfonamide(Non-covalent)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Swain, N.A. et al., Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7. J. Med. Chem. (2017)
Release Date
2017-06-07
Peptides
Cytochrome P450 2C9: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Cytochrome P450 2C9

Related Entries With Identical Sequence

1r9o.1 | 5a5i.1 | 5a5j.1 | 5w0c.1